Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
140.87
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S ADR
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
51
52
Next >
Why Novo Nordisk Stock Was Tumbling on Thursday
September 21, 2023
A downbeat analyst take resonated with investors.
Via
The Motley Fool
Coca-Cola Short Seller Says Dominance Fizzles In Face Of Bubbly Upstarts, Weight Loss Drugs
September 21, 2023
Coca-Cola short seller says market dominance is fading to competitors and weight-loss drugs such as Ozempic.
Via
Benzinga
Novo Nordisk Unusual Options Activity For September 21
September 21, 2023
Via
Benzinga
FDA Inspection Turns Up 'Objectionable' Bacteria In Key Novo Nordisk Plant
September 21, 2023
The company says it has since corrected the issues found in the FDA inspection.
Via
Investor's Business Daily
Exposures
Product Safety
Why Novo Nordisk Stock Edged Higher Today
September 20, 2023
The good news outweighed the bad for the hot drug developer on Hump Day.
Via
The Motley Fool
Ypsomed To Supply Autoinjectors To Novo Nordisk Under Long-Term Agreement
September 20, 2023
Swiss medical technology company Ypsomed (OTC: YPHDF) announced a long-term supply
Via
Benzinga
Why Novo Nordisk Stock Dipped Today
September 18, 2023
Popularity has its downsides.
Via
The Motley Fool
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,700 Today
September 14, 2023
Via
Benzinga
Should You Buy Ozempic Maker Novo Nordisk Before Its Stock Split?
September 14, 2023
The upcoming stock split isn't the main story with this high-flying pharma stock.
Via
The Motley Fool
Eli Lilly Cracks Down on Counterfeit Mounjaro Wight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics
September 20, 2023
Eli Lilly And Co (NYSE: LLY) has taken
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
September 19, 2023
Bloomberg
Via
Benzinga
Novo Nordisk Partners With South Africa-Based Aspen To Supply Insulin For African Countries
September 19, 2023
Novo Nordisk A/S (NYSE: NVO) announced a new partnership with&
Via
Benzinga
Single Bitcoin In 2021 Was Enough To Purchase A Tesla Model Y, Softbank Explores Investing In OpenAI, Ford Faces UAW Strike In US, Canada: Today's Top Stories
September 18, 2023
Benzinga
Via
Benzinga
This Is What Whales Are Betting On Novo Nordisk
September 13, 2023
Via
Benzinga
Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant
September 18, 2023
The FDA reportedly inspected a Novo facility charged with making diabetes and weight-loss drugs.
Via
Investor's Business Daily
Exposures
Product Safety
Quality Control Issues at Novo Nordisk's Clayton Plant - Key Site for Weight-Loss, Diabetes Drug Production
September 18, 2023
The FDA has reportedly issued a report detailing quality control lapses at Novo Nordisk A/S's (NYSE: NVO) Clayton, North Carolina plant.
Via
Benzinga
Exposures
Product Safety
3 Phenomenal Stock-Split Stocks You Should Be Buying Now
September 18, 2023
These three fantastic stock-split stocks are stocks investors should be buying in the wake of last year's wave of splits.
Via
InvestorPlace
3 Stock-Split Stocks Billionaire Investors Can't Stop Buying
September 18, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three highfliers Wall Street's top managers are piling into.
Via
The Motley Fool
Yet Again, Ozempic Could Soon Get Even Better for Novo Nordisk Stock
September 16, 2023
The results of a small new study could open the door to yet another market.
Via
The Motley Fool
The 7 Most Undervalued Cathie Wood Stocks to Buy in September 2023
September 15, 2023
Elevate your portfolio with these Cathie Wood's undervalued stocks brimming with robust long-term growth potential
Via
InvestorPlace
3 (Bad) Reasons to Avoid or Sell Novo Nordisk Stock
September 15, 2023
The rhetoric surrounding popular businesses isn't always good advice.
Via
The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
September 15, 2023
Revenue at all three companies improved last quarter, and their share prices have followed suit.
Via
The Motley Fool
This Stock Is Lifting an Entire Country's Economy -- Is It a Buy?
September 14, 2023
The drugmaker is clearly firing on all cylinders.
Via
The Motley Fool
Topics
Economy
Exposures
Economy
Is This a Dead-Cat Bounce? 3 Must-Buy Stocks Just in Case.
September 13, 2023
History suggests the market is ready to run higher, but it could also be a false positive that results in a dead-cat bounce.
Via
InvestorPlace
Should You Buy NVO Stock Ahead of the Novo Nordisk Stock Split?
September 13, 2023
Ozempic producer Novo Nordisk is about to split its stock again. Here's why investors should be watching NVO stock closely.
Via
InvestorPlace
Madrigal Pharmaceuticals Surges As Its NASH Treatment Toes The Long-Awaited Finish Line
September 13, 2023
The company is toeing the finish line with a NASH treatment, an area of medicine marked by failures.
Via
Investor's Business Daily
Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?
September 13, 2023
Eiger BioPharmaceuticals (EIGR) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial.
Via
InvestorPlace
Why Is Calidi Biotherapeutics (CLDI) Stock Down 36% Today?
September 13, 2023
Calidi Biotherapeutics (CLDI) stock is taking a beating on Wednesday following the clinical-stage biotechnology company's public debut.
Via
InvestorPlace
Why Is Avalo Therapeutics (AVTX) Stock Up 69% Today?
September 13, 2023
Avalo Therapeutics (AVTX) stock is taking off on Wednesday after the biotechnology company announced a $45 million asset sale.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 13, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Via
InvestorPlace
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.